Bibliographical novelties by Facultad de Farmacia (Universidad de Granada)




Editor: Ángel Gil Hernández
Coedi tores
Tomo I
Fermín Sánchez de Medina Contreras
Tomo II
Mª Dolores Ruiz López
Tomo III
Enma Camarero González





Abelardo García de Lorenzo y Mateos
Juan Carlos Montejo González
Mercé Planas Vilá
WHO Expert Committee on Biological
Standardizat ion
Fifty-second Report




Developments in biological standardization 2
Bioterrorism 4




recommendations and other matters
related to the manufacture and quality
control of biologicals 7
Guidelines on clinical evaluation of
vaccines: regulatory expectations 7
Group C meningococcal conjugate
vaccines 8
Inactivated oral cholera vaccines 9
Guidelines on viral inactivation and
removal procedures intended
to assure the viral safety of human blood
plasma products 10
Pneumococcal conjugate vaccines 11




Ars Pharm 2005; 46 (1): 105-106.
NOVEDADES BIBLIOGRÁFICAS
Preventive human immunodeficiency virus
vaccines 13
Cell substrate safety 14
Cell banks 15
Yellow fever 16
Poliomyelitis vaccine, oral 16
Transmissible spongiform encephalitis and
the safety of biologicals 18
Antivenoms 18
Gene therapy 20
Discontinuation of requirements and
guidelines 20
International reference materials 21
Biological substances: international
standards and referente reagents 21
International biological standards for in
vitro diagnostic procedures 22
International reference materials for the
diagnosis and study of transmissible
spongiform encephalitis 23
Antibodies 24
Human antibody against human platelet
antigen 5b 24
Blood products and related substances
2 4
International reference panels for the
validation of serological and nucleic acid
based test for the detection of hepatitis B,
hepatitis C and human immunodeficiency
virus in blood screening 24
Factors II, VII, IX, X, Plasma 26
Von Willebrand factor 27
Streptokinase 29
Unfractionated heparin and low-molecular-
weight heparin 30
Cytokines, growth factors and
endocrinological substances 31
Human chorionic gonadotrophin 31
Ciliary neurotrophic factor 32
Prolactin and its glycosylated and non-
glycosylated components 32
Miscellaneous 33
Pertussis toxin standard 33
Annex 1
Guidelines on clinical evaluation of vaccines:
regulatory expectations 35
Annex 2
Recommendations for the production and
control of meningococcal group C
conjugate vaccines 102
Annex 3
Guidelines for the production and control of
inactivated oral cholera vaccines 129
Annex 4
Guidelines on viral inactivation and removal
procedures intended to assure the viral safety
of human blood plasma products 150
Annex 5
Biological substances: international standards
and reference reagents 225
Annex 6
Recommendations and guidelines for
biological substances used in medicine
and other documents 228
